Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner  by Nogueiras, Rubén et al.
Resistin is expressed in di¡erent rat tissues and is regulated in
a tissue- and gender-speci¢c manner
Rube¤n Nogueirasa, Rosal|¤a Gallegob, Oreste Gualilloc, J. Eduardo Caminosa,
Toma¤s Garc|¤a-Caballerob, Felipe F. Casanuevad, Carlos Die¤gueza;
aDepartment of Physiology, University of Santiago de Compostela, School of Medicine, 15705 Santiago de Compostela, Spain
bDepartment of Morphological Sciences, University of Santiago de Compostela, School of Medicine, 15705 Santiago de Compostela, Spain
cHospital Cl|¤nico Universitario de Santiago, University of Santiago de Compostela, School of Medicine, 15705 Santiago de Compostela, Spain
dDepartment of Medicine-Molecular Endocrinology Section, University of Santiago de Compostela, School of Medicine,
15705 Santiago de Compostela, Spain
Received 14 January 2003; revised 10 June 2003; accepted 11 June 2003
First published online 4 July 2003
Edited by Robert Barouki
Abstract Resistin is a polypeptide hormone ¢rst reported from
human and rodent adipocytes. In order to better de¢ne the po-
tential biological role of resistin we undertook a detailed anal-
ysis of its expression in di¡erent rat tissues. We demonstrate by
real-time reverse transcription polymerase chain reaction,
Southern blotting and immunohistochemistry that resistin is ex-
pressed not only in brown and white adipose tissue, but also in
the stomach, small and large intestines, adrenal gland, and skel-
etal muscle. Food deprivation led to a decrease in resistin
mRNA expression only in adipose tissue, not in any of the other
tissues studied. Furthermore, resistin mRNA expression is high-
er in males than in females in adipose tissue, not in any of the
other tissues. Thus, our data suggest that resistin is not exclu-
sively localized in adipocytes, and indicate that its expression is
regulated in a tissue- and sex-speci¢c manner.
& 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Resistin is a recently discovered 12.5-kDa cysteine-rich se-
creted polypeptide ¢rst reported from rodent adipocytes [1,2].
It belongs to a multigene family termed RELMs or FIZZ
proteins [3,4]. Plasma resistin levels are signi¢cantly increased
in both genetically susceptible and high-fat-diet-induced obese
mice. Interestingly, immunoneutralization of resistin improves
hyperglycemia and insulin resistance in high-fat-diet-induced
obese mice, while administration of recombinant resistin im-
pairs glucose tolerance and insulin action in normal mice [1].
More recently, it was demonstrated that increases in circulat-
ing resistin levels markedly stimulate glucose production in
the presence of ¢xed physiological insulin levels [5], whereas
insulin suppressed resistin expression [6]. Taken together,
these results suggested that resistin could be a link between
obesity and type 2 diabetes [7^9].
Initial studies on resistin regulation have indicated that its
gene expression is reduced by fasting [1,2]. It has also been
reported that circulating resistin levels are raised in genetically
obese (ob/ob, db/db) mice [1]. In keeping with this, resistin
mRNA levels were down-regulated by chronic food restriction
in normal and pregnant female rats [10]. Thus, it appears that
resistin levels are markedly in£uenced by nutritional status. In
addition, resistin is regulated by testosterone [10,11], glucocor-
ticoids [6,12], endothelin-1 [13], growth hormone [14], tumor
necrosis factor-K [15], lipopolysaccharide [16], and thyroid
hormones [10], which exert their e¡ects in many di¡erent tis-
sues. In this connection, it is well known that most of the
bioactive peptides secreted by adipocytes, and notably leptin
[17], are also synthesized in many other tissues, where they
play a variety of di¡erent roles [18,19]. Like leptin [20], resis-
tin is regulated by gonadal hormones. Some authors have
reported that resistin levels are higher in fat from female
than from male mice [1], but the opposite pattern has been
reported for rats [10]. It is not clear whether this discrepancy
re£ects a genuine interspecies di¡erence, or simply the fact
that the mouse study did not con¢rm the statistical signi¢-
cance of the observed di¡erences. Recently, Morash et al.
[21] reported that resistin is not exclusively synthesized in
adipocytes, since resistin mRNA is also observed in mouse
brain and pituitary. In humans, in addition to white adipose
tissue (WAT), resistin has also been found in monocytes
[22,23] and placenta [24].
The aim of this work was to analyze the expression of
resistin in di¡erent rat tissues, and to study the tissue-speci¢c
regulation of resistin mRNA levels in relation to sex and food
deprivation.
2. Materials and methods
2.1. Animals
We used male and female Sprague^Dawley rats (200^250 g). The
animals were housed at 23‡C under a 12-h light^darkness cycle with
free access to food (depending on the requirements of each experi-
ment) and water. All experiments were carried out in accordance with
standards approved by the Faculty Animal Committee.
2.2. Experimental setting 1
Resistin mRNA expression was analyzed in various peripheral tis-
sues of adult male rats. Animals were killed by decapitation, and all
tissues were rapidly explanted, snap-frozen on dry ice, and stored at
380‡C until use.
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2.3. Experimental setting 2
To assess possible sex di¡erences in resistin mRNA expression lev-
els, adult male and female rats were used. Animals were killed by
decapitation, and the di¡erent tissues were explanted, snap-frozen
on dry ice, and stored at 380‡C until use. To investigate the e¡ect
of fasting on resistin mRNA, two groups of adult male rats (one fed
ad libitum, the other fasted for 72 h) were used.
2.4. RT-PCR and Southern blot analysis
Total RNA was extracted with the Trizol reagent (Invitrogen,
Carlsbad, CA, USA) and 2 Wg of this RNA was used to perform
reverse transcription polymerase chain reaction (RT-PCR). Comple-
mentary DNA was synthesized using 200 U of Moloney murine leu-
kemia reverse transcriptase (Invitrogen), 40 U of RNase Out (re-
combinant ribonuclease inhibitor; Invitrogen), 200 nM deoxy-NTP
mixture, 15 mM MgCl2, and 1 nM random hexamer primers, in a
total volume of 30 Wl. The reaction mixtures were incubated at 37‡C
for 1 h and at 42‡C for 10 min. The RT reaction was terminated by
heating at 95‡C for 5 min. The ampli¢cation mixture was as follows:
1UPCR bu¡er [200 mM Tris^HCl pH 8.4 and 500 mM KCl (Invi-
trogen)], 50 mM MgCl2, 200 nM deoxy-NTP mixture, 1 nM rat re-
sistin upstream primer 5P-ACTTCAGCTCCCTACTGCCA-3P, 1 nM
rat resistin downstream primer 5P-GCTCAGTTCTCAATCAACC-
GTCC-3P, and 1.25 U of Taq DNA polymerase (Invitrogen).
The primers used in the ampli¢cation of rat CD45 were 5P-TG-
TGAACATACGGATTGTGAA-3P upstream primer and 5P-CTAT-
GTCTGGTGTGCAGTTTG-3P downstream primer.
The primers used in the ampli¢cation of rat aP2 were 5P-GACCTG-
GAAACTCGTCTCCA-3P upstream primer and 5P-CATGACACAT-
TCCACCACCA-3P downstream primer.
PCR ampli¢cation cycle parameters were as follows: denaturation
at 95‡C for 30 s, annealing at 60‡C for 1 min, and extension at 72‡C
for 1 min. The ¢nal step was extension at 72 ‡C for 10 min.
To con¢rm the quality of the mRNA in each sample, it was am-
pli¢ed together with L-actin (forward primer 5P-TACAACTCCTTG-
CAGCTCC-3P and reverse primer 5P-ATCTTCATGAGGTAGTCA-
GTC-3P). The PCR ampli¢cation generated a single 273-bp rat resistin
product, a 162-bp rat CD45 product, a 349-bp rat aP2 product, and a
single 601-bp L-actin product.
PCR products were separated on 1.5% agarose gel, stained with
ethidium bromide and examined with UV light using a Gel Doc
1000 Documentation System (Bio-Rad Laboratories, Hercules, CA,
USA). To con¢rm authenticity of the amplimers, a Southern blot
analysis was carried out. Hybridization of nylon-transferred resolved
amplicons was performed using a 32P cDNA probe speci¢c for rat
resistin [10]. Hybridization was carried out at 42‡C for 18 h. After
removing the excess labeled probe by washing, the hybridization pat-
terns were revealed by autoradiography.
2.5. Analysis of resistin gene expression by real-time RT-PCR
Real-time RT-PCR analyses were performed in a £uorescent tem-
perature cycler (LightCycler, Roche Molecular Biochemicals, Mann-
heim, Germany) as per the manufacturer’s instructions. Two micro-
grams of total RNA were used for each RT reaction. The 20-Wl
ampli¢cation mixture contained 2 Wl of RT reaction products plus
3 mM MgCl2, 0.5 WM of each primer, and 1ULightCycler DNA
Master SYBR Green I mix (Roche Molecular Biochemicals). After
initial denaturation at 94‡C for 30 s, reactions were cycled 34 times
using the following parameters for resistin detection: denaturation at
95‡C for 1 s, annealing at 60‡C for 7 s, and extension at 72‡C for 11 s.
rHPRT cDNA was ampli¢ed under the same conditions. The amount
of PCR products formed in each cycle was evaluated on the basis of
SYBR Green I £uorescence. At the end of each run, melting curve
pro¢les were produced (cooling the sample to 68‡C and heating slowly
to 95‡C, with continuous measurement of £uorescence) to con¢rm
ampli¢cation of speci¢c transcripts (data not shown). The oligonu-
cleotide primers speci¢c for rat resistin are described above. Cycle-to-
cycle £uorescence emission readings were monitored and quanti¢ed
using the second derivative maximum method of the LightCycler soft-
ware package (Roche Molecular Biochemicals). This method deter-
mines the crossing points of individual samples by an algorithm
that identi¢es the ¢rst turning point of the £uorescence curve. This
turning point corresponds to the ¢rst maximum of the second deriv-
ative curve and correlates inversely with the log of the initial template
concentration. Resistin mRNA levels were normalized with respect to
of rHPRT level in each sample.
2.6. Immunohistochemistry
Samples of normal brown (BAT) and WAT, skeletal muscle, adre-
nal gland, stomach (fundus and pylorus), small bowel (duodenum)
and liver were immersion-¢xed in 10% bu¡ered formalin for 24 h,
then dehydrated and embedded in para⁄n by a standard procedure.
Sections 5 Wm thick were mounted on Histobond adhesion slides
(Marienfeld, Lauda-Ko«nigshofen, Germany), then dewaxed and rehy-
drated. For immunohistochemical staining, two di¡erent antibodies
were used: anti-mouse resistin raised in guinea pig (Linco, St. Charles,
MO, USA) and anti-human resistin raised in rabbit (Phoenix Phar-
maceuticals, Belmont, CA, USA). With the antiserum against anti-
human resistin, the Envision dextran polymer method was employed
as detection system. The sections were incubated in (1) rabbit anti-
human resistin antibody diluted 1/2000 for 1 h at room temperature,
(2) 3% hydrogen peroxide for 10 min, (3) Envision/horseradish per-
oxidase rabbit/mouse (Dako) for 30 min, and (4) diaminobenzidine.
Negative controls were performed by replacing the anti-resistin anti-
body with Tris-bu¡ered saline (TBS), or with normal rabbit serum at
the same concentration as the primary anti-human resistin antibody.
This antibody shows 0% cross-reactivity with insulin, leptin and ghre-
lin, and its speci¢city for resistin has been demonstrated previously
[21,25,26].
2.7. Statistical analysis
Mean resistin mRNA levels were compared between groups by
analysis of variance followed by a post-hoc multiple comparison
test. P values 6 0.05 were considered statistically signi¢cant.
3. Results
3.1. Expression of resistin in di¡erent rat tissues
Resistin mRNA expression was analyzed in various periph-
eral tissues of adult male rats (Fig. 1). In addition to its ex-
pression in WAT, resistin-speci¢c DNA fragments were am-
pli¢ed by RT-PCR from RNA in BAT, stomach, large and
small intestine, adrenal gland, and skeletal muscle (Fig. 1A).
These results were con¢rmed by Southern blot analysis (Fig.
1B). Quanti¢cation of resistin mRNA levels by real-time RT-
PCR, in all cases normalized with respect to rHPRT levels,
indicates that resistin mRNA expression levels were highest in
WAT and BAT and lower in all other tissues studied (Fig.
1D) and the results show that, while WAT is the tissue with
highest levels, BAT, stomach, duodenum, jejunum, ileum, co-
lon, adrenal gland, and skeletal muscle also express resistin
mRNA. In the remaining tissues, resistin mRNA was almost
undetectable.
To verify that the presence of resistin in the di¡erent tissues
was not a consequence of white blood cell contamination, we
assessed resistin mRNA expression in rat blood, ¢nding that
is not present in this tissue (Fig. 2A). We also investigated
whether CD45 (a marker of mononuclear cells) is expressed in
the tissues in which resistin was located, ¢nding that it is
present only in blood, not in any other tissue (Fig. 2B). Like-
wise, to verify that the presence of resistin was not a conse-
quence of adipocyte contamination, we tested for mRNA of
aP2 (an adipocyte-speci¢c mRNA), which we detected only in
WAT and BAT (Fig. 2C) as previously reported [27,28].
To further explore resistin expression in these tissues, we
carried out an immunohistochemical study with two speci¢c
antibodies (directed to mouse and human resistin, respec-
tively). With human resistin antiserum, we observed an in-
tense immunostaining for resistin in both BAT (Fig. 3a) and
WAT (Fig. 3b). Weak immunoreactivity was observed in du-
odenum, mainly the epithelial lining and crypts (Fig. 3c). In
the stomach (fundic and pyloric mucosa), intense resistin im-
munoreactivity was observed, primarily in oxyntic cells (Fig.
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3d) and neuroendocrine cells (Fig. 3e). Skeletal muscle cells
also showed intense immunostaining (Fig. 3f). Less intense
immunoreactivity was observed in the adrenal cortex (Fig.
3g). Finally, no immunoreactivity was observed in the liver
(Fig. 3h). The same localizations were observed with both
antibodies used. Negative controls were performed by replace-
ment of the primary antibody with TBS or normal serum: in
no case was immunoreaction observed. Similar results were
obtained using an anti-mouse resistin antiserum (data not
shown).
3.2. In£uence of gender on resistin mRNA levels
As shown in Fig. 4A, assessment of resistin mRNA levels in
male and female rat tissues by real-time RT-PCR indicated
Fig. 1. Resistin mRNA expression in di¡erent rat tissues after 34 cycles of ampli¢cation: RT-PCR (A), Southern blot (B), L-actin (C). Semi-
quantitative resistin mRNA levels in the di¡erent tissues, as measured by real-time RT-PCR over the same number of cycles, normalized with
respect to endogenous rHPRT mRNA levels (D). Histograms with di¡erent superscript letters are statistically di¡erent (b=P6 0.05;
c =P6 0.01 and d=P6 0.001).
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signi¢cantly higher levels in males than females in WAT and
BAT, but no sex di¡erence in any of the other tissues studied.
3.3. In£uence of fasting on resistin mRNA levels
In order to investigate the possible in£uence of nutritional
status, we determined resistin mRNA levels after complete
food deprivation for 72 h, in all the tissues in which resistin
had been detected. Our results (Fig. 4B) indicate that resistin
mRNA levels in WAT of fasted rats were lower than in non-
fasted rats. No e¡ect of fasting was observed in any of the
other tissues studied.
4. Discussion
Resistin is a signaling molecule that was ¢rst reported as a
protein secreted speci¢cally by adipocytes [1]. However, it has
very recently been demonstrated that resistin mRNA was ex-
pressed in mouse brain and pituitary [21] and in the brown
adipocyte cell line T37i [29]. Available data on resistin gene
expression in humans are rather contradictory. Some authors
have reported that mononuclear blood cells express resistin
[22,30,31] and that increased resistin mRNA expression in
adipose tissue biopsies from obese patients could be due to
a greater abundance of mononuclear cells in adipose tissue
from obese patients; however, other authors have reported
that adipose-tissue-depot-speci¢c resistin protein and mRNA
expression is not due to the presence of peripheral blood
mononuclear cells [26].
In order to gain further insight into the physiological role
of resistin, we decided to carry out a detailed analysis of its
expression in di¡erent rat tissues, using real-time RT-PCR,
Southern blotting and immunohistochemistry. We observed
that resistin is not secreted exclusively by adipose tissue, but
is also expressed in the gastrointestinal tract, adrenal gland,
and skeletal muscle. The expression of resistin in the gastro-
intestinal tract and the variation in resistin mRNA levels in
Fig. 2. Representative RT-PCR analysis showing absence of resistin mRNA expression in blood cells after 32 cycles (A). Representative
RT-PCR analysis showing presence of CD45 mRNA in blood but not in any of the tissues in which resistin was detected (B). Representative
RT-PCR analysis of aP2 mRNA expression in all the tissues in which resistin was detected (C). The quality of the mRNA was tested by paral-
lel ampli¢cation of L-actin.
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adipose tissue depending on nutritional status (levels reduced
by fasting, increased by refeeding) [1,2] suggest that this pro-
tein may play a role in the maintenance of metabolic homeo-
stasis. The distribution of resistin mRNA in the gastrointesti-
nal tract is similar to that of peroxisome proliferator-activated
receptor-Q (PPAR-Q), a factor that clearly increases insulin
sensitivity in vivo, and that markedly reduces resistin gene
expression and protein secretion [32^34]. PPAR-Q has been
reported to be expressed in the stomach, duodenum, jejunum
and colon, but not in the liver [35]. In contrast, very low levels
of expression of PPAR-Q were reported in skeletal muscle and
the adrenal gland [36]. Our data do not support a clear rela-
tionship between PPAR-Q and resistin gene expression,
although it would certainly be interesting to perform a colo-
calization analysis of resistin and PPAR-Q in the tissues
studied; independently of this, the present study has identi¢ed
cell populations expressing resistin in adult rats, which sug-
gests possible future directions for investigating the functions
of this protein. However, until the receptor for resistin is
characterized, it will be di⁄cult to clarify its physiological
role(s) in the di¡erent tissues in which it is present.
The presence of resistin in human mononuclear cells raises
the possibility that the wide tissue distribution of resistin
mRNA could be due to the presence of blood cells. However,
and in agreement with date obtained in mice [21], we failed to
detect resistin mRNA in rat blood cells. Likewise, we veri¢ed
that the mononuclear cell marker CD45 is not expressed in
any of the tissues in which resistin was detected. So, we dem-
onstrate by RT-PCR that resistin expression in di¡erent tis-
sues is not due to contamination by monocytes. Another pos-
sibility is that the wide tissue distribution of resistin re£ects
the presence of adipocytes. To investigate this possibility, we
tested for the adipose-speci¢c marker aP2; however, we only
detected mRNA of this protein in WAT and BAT, in which it
has been previously reported [27,28], not in any of the other
tissues in which resistin was detected. Taken together, these
results indicate that the detection of resistin mRNA was not
due to the presence of monocytes or adipocytes.
Furthermore, immunohistochemistry performed with two
speci¢c antibodies (anti-human and anti-mouse resistin) dem-
onstrated that resistin is localized in speci¢c cells in each tissue
(for example, oxyntic and neuroendocrine cells in the stom-
ach; villi and crypts in the duodenum, cortical cells in adrenal
gland); by contrast, no immunoreactivity was detected in
mononuclear blood cells in any of the di¡erent tissues.
Thus, whereas some authors have identi¢ed resistin in human
blood mononuclear cells, in our experiments performed in
rats, we were unable to corroborate this result. The reason
for this could be the great variation in the organization of the
resistin sequences in the di¡erent species [37], and this prob-
ably explains the functional di¡erences between mouse and
human resistin.
Having con¢rmed that resistin is widely expressed in di¡er-
ent rat tissues, we decided to assess whether its levels are
Fig. 3. Resistin immunoreactivity (human resistin antibody) was localized in: (a) BAT (objective magni¢cation U40); (b) WAT (U40); (c) epi-
thelial lining of villus and crypts of the duodenum (U40); (d) oxyntic cells of gastric fundic glands (U20); (e) neuroendocrine cells (arrows) of
the pyloric region (U40); (f) skeletal striated muscle ¢bers (U40); and (g) adrenal cortex (U20). No immunostaining was observed in (h) liver
(U20).
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regulated in a tissue-speci¢c fashion. Speci¢cally we assessed
resistin mRNA levels in fed and fasted rats. In agreement with
previous data [1,2], we found that resistin mRNA levels were
decreased in WAT of fasted rats in comparison with ad-libi-
tum-fed rats. Nutritional status appears to a¡ect only WAT
resistin levels but not resistin levels in any of the other tissues
studied.
We then assessed the in£uence of gender on resistin mRNA
levels in all the tissues in which this hormone was detected.
Previously, our laboratory has demonstrated that WAT resis-
tin mRNA expression is higher in males than in females at all
ages studied [10]. In the present study we found that resistin is
in£uenced by gender in a tissue-speci¢c manner: its expression
is higher in WAT and BAT of male rats than of female rats,
but its levels do not di¡er between genders in the other tissues
studied. This suggests that resistin may play di¡erent roles in
males and females; however, the full signi¢cance of this result
is unknown, and further studies must be performed to explore
the physiological role of this hormone in the sexes.
In summary, this study provides the ¢rst evidence (a) that
resistin is expressed in di¡erent rat tissues; (b) that in fasted
rats, resistin mRNA expression decreases in WAT but not in
other tissues; and (c) that resistin mRNA expression is higher
in male than female rats in WAT and BAT, but not in other
tissues.
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